Urinary Chemokines CXCL9 and CXCL10 Are Non-Invasive Biomarkers of Kidney Transplant Rejection

Ernesta Mačionienė; Martynas Simanavičius; Monika Vitkauskaitė; Alvita Vickienė; Roberta Staučė; Artūras Vinikovas; Marius Miglinas

doi:10.12659/AOT.944762

15 October 2024 : Original article

Urinary Chemokines CXCL9 and CXCL10 Are Non-Invasive Biomarkers of Kidney Transplant Rejection

Ernesta Mačionienė

^1ABCDEFG*, Martynas Simanavičius^2BE, Monika Vitkauskaitė^1BC, Alvita Vickienė^1B, Roberta Staučė^3B, Artūras Vinikovas^3B, Marius Miglinas^1ADEF

DOI: 10.12659/AOT.944762

Ann Transplant 2024; 29:e944762

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 6 Kidney graft survival (time from kidney biopsy to initiation of dialysis) of patients with low and high levels of CXCL9/cre (A) and CXCL10/cre (B). The figure was created with SPSS 29.0 (SPSS, Inc, Chicago, IL, USA).

Back to the Article

Urinary Chemokines CXCL9 and CXCL10 Are Non-Invasive Biomarkers of Kidney Transplant Rejection

Your Privacy